|
Carmen Ortega-Sabater (BSc in Biology and MSc in Experimental Oncology, University of Murcia, and MSc in Applied Mathematics, University of Castilla-La Mancha) is a Ph.D. student funded by the Spanish Association Against Cancer (AECC). She is studying mathematically the mechanisms behind phenotypic plasticity and also malignancy evolution in pediatric leukemias and brain metastases using single-cell karyotyping and scRNA-seq data and working in collaboration with Josep Carreras Leukemia Research Institute and CNIO. |
- Integrative CellOmics for precision medicine in childhood leukemia: A coordinated eHealth action for cancer biodigitization (LEUKODOMICS)
Ministery of Science and Innovation (NextGenerationEU) (2023 - 2024) - Improving New Therapies in Oncology and Related Fields using mathematical models and biomedical data
Ministry of Science and Innovation (National Research Plan) (2023 - 2026) - Mathematical models for the digital transition in neuro-oncology: In-silico design of a clinical trial for glioblastoma.
Ministerio de Ciencia e Innovación (NextGenerationEU) (2023 - 2024) - Validation and transfer of oncological data and biomarkers based on mathematical models (AFTERbioMATH)
Ministry of Science and Innovation (Spain), Proof of Concept Program (2023 - 2024) - Mathematical models in Oncology
Ministerio de Ciencia e Innovación (Spain) (2020 - 2023)
Carmen Ortega-Sabater (BSc in Biology and MSc in Experimental Oncology, University of Murcia, and MSc in Applied Mathematics, University of Castilla-La Mancha) is a Ph.D. student funded by the Spanish Association Against Cancer (AECC). She is studying mathematically the mechanisms behind phenotypic plasticity and also malignancy evolution in pediatric leukemias and brain metastases using single-cell karyotyping and scRNA-seq data and working in collaboration with Josep Carreras Leukemia Research Institute and CNIO. |
- Integrative CellOmics for precision medicine in childhood leukemia: A coordinated eHealth action for cancer biodigitization (LEUKODOMICS)
Ministery of Science and Innovation (NextGenerationEU) (2023 - 2024) - Improving New Therapies in Oncology and Related Fields using mathematical models and biomedical data
Ministry of Science and Innovation (National Research Plan) (2023 - 2026) - Mathematical models for the digital transition in neuro-oncology: In-silico design of a clinical trial for glioblastoma.
Ministerio de Ciencia e Innovación (NextGenerationEU) (2023 - 2024) - Validation and transfer of oncological data and biomarkers based on mathematical models (AFTERbioMATH)
Ministry of Science and Innovation (Spain), Proof of Concept Program (2023 - 2024) - Mathematical models in Oncology
Ministerio de Ciencia e Innovación (Spain) (2020 - 2023)